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and translational medicine forwardWelcome to the inaugural issue of Genes & Diseases, a peer-
reviewed international journal that aims to facilitate a
rapid dissemination and exchange of scientific advances
about human diseases between basic science investigators
and physicians worldwide.
Genes & Diseases focuses on publishing investigations
on the molecular bases and experimental therapeutics
of human diseases. Human medicine is undoubtedly a
rapidly evolving field. The journal’s emphasis is placed on
hypothesis-driven, mechanistic studies relevant to the
pathogenesis and/or experimental therapeutics of human
diseases. Thus, Genes & Diseases has a broad scope in basic
and translational biomedical research related to molecular
biology, molecular genetics, cell biology, and experimental
medicine. The current publication formats include full
length research article, review article, short communica-
tion, correspondence, perspectives, commentary, views on
news, and research watch.
As Genes & Diseases is devoted to publishing articles
pertaining in the broad context to human diseases, our goal
is to make the journal into one of the preeminent re-
positories of knowledge and platforms for basic and trans-
lational research in medicine. The peer review process will
match knowledgeable reviewers with submitted manu-
scripts to produce high quality articles of interest and sci-
entific merit. We are guided by the conviction that the
ultimate goal of biomedical research is to prevent and treat
human diseases. Thus, the highest priority will be given to
publishing studies that may significantly advance human
health.
We are experiencing an era of rapid change and trans-
formation in human medicine, driven mostly by new techno-
logical advances. Since the completion of the human genome
sequencing project in the early 2000’s, next-generation
sequencing technologies and the big data era have
emerged, and have had a major impact on understanding the
pathogenesis and developing innovative therapeutics forPeer review under responsibility of Chongqing Medical
University.
http://dx.doi.org/10.1016/j.gendis.2014.08.003
2352-3042/Copyright ª 2014, Chongqing Medical University. Productionhuman diseases. Next-generation sequencing-based analyses
not only offer unprecedented opportunities to unravel the
molecular bases of human diseases, but also to move
personalizedmedicine closer to reality than ever before. The
recent development of induced pluripotent stem (iPS) cell
technology should further enable us to generate individual
derived iPS cells to model disease development, to study
organ genesis, to develop new therapeutic strategies, and
to repair damaged tissues or organs through regenerative
medicine.
It is exciting to behold the medical field entering a
golden age of applications of bench findings to create
dramatic clinical improvements in the diagnosis, prognosis,
and treatment of human diseases. Genes & Diseases will
leverage findings from basic and translational research, as
well as innovative methods and technologies in biomedical
sciences, which should ultimately lead to the development
of novel diagnostics and therapeutics, as well as effective
preventive measures, for human diseases. Our hope is that
Genes & Diseases will provide high quality and stimulating
papers with cutting-edge information for both physicians
and basic science investigators.
We are proud to present our distinguished Editorial
Board consisting of experts from the basic and medical
research communities worldwide (see below). We wish to
extend our gratitude to both the members of the Editorial
Board and the Editorial Office staff, as they are the
backbone of this scientific endeavor and have graciously
given their time and effort to ensure the successful
launch of Genes & Diseases. We couldn’t envision starting
this journal without the support and professionalism of
these established investigators interested in this fasci-
nating field of biomedical research and wishing to make
our journal a success. We also want to thank our con-
tributors for sharing their research, as well as knowledge
and expertise, to generate this inaugural issue of Genes &
Diseases.
Please enjoy this inaugural issue. We hope you will
consider Genes & Diseases when deciding where to submit
your next paper. We are confident that with your supportand hosting by Elsevier B.V. All rights reserved.
2 Editorialand participation, Genes & Diseases will become an
outstanding forum for the presentation of molecular and
translational medical research.
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